Metabolic Stack
GLP-1 + mitochondrial optimization
How This Stack Works
Tirzepatide acts on both GLP-1 and GIP receptors to regulate appetite signalling, glucose disposal, and fat metabolism from the top down — through hormonal and neurological pathways. MOTS-C is a mitochondrial-derived peptide that activates AMPK, improving insulin sensitivity and energy metabolism at the cellular level. Together they represent a top-down hormonal approach paired with a bottom-up cellular approach to metabolic health.
Why This Combination Works
Tirzepatide's GLP-1/GIP dual agonism regulates appetite and glucose at the systemic level — reducing caloric intake and improving pancreatic insulin secretion. MOTS-C acts at the mitochondrial level to make cells more responsive to insulin independent of pancreatic function. This means the stack addresses insulin resistance at every level simultaneously: appetite, secretion, and cellular uptake. Neither mechanism interferes with the other; they stack purely additively.
Benefits in Detail
Dual GLP-1/GIP Receptor Activation
Tirzepatide's unique dual-agonism on GLP-1 and GIP receptors produces superior weight loss outcomes compared to GLP-1-only agonists in clinical trials. GIP receptor activation adds metabolic benefits beyond appetite suppression — including improved lipid metabolism and adipocyte function.
AMPK Activation & Mitochondrial Health
MOTS-C activates AMPK — often called the 'master metabolic switch' — which drives fatty acid oxidation, glucose uptake, and mitochondrial biogenesis. This produces effects similar to exercise at the cellular level, making it particularly studied in the context of metabolic disease and longevity.
Superior Insulin Sensitivity
MOTS-C improves insulin sensitivity independently of body weight — a critical distinction. Even at equal body weights, MOTS-C-treated subjects show dramatically improved glucose uptake. Combined with Tirzepatide's improvement in insulin secretion, this stack addresses both sides of the insulin equation.
Sustainable Fat Loss
Tirzepatide's appetite regulation combined with MOTS-C's metabolic rate support creates conditions for fat loss without the compensatory metabolic slowdown that characterises caloric restriction alone. The body's set point is lowered while cellular fat-burning capacity is simultaneously increased.
Cardiovascular Risk Reduction
Both GLP-1 receptor agonism and AMPK activation have demonstrated cardiovascular protective effects in studies — reducing arterial inflammation, improving lipid profiles, and protecting against atherogenesis. This stack's cardiovascular benefits extend well beyond body weight.
Longevity Pathway Activation
MOTS-C is derived from mitochondrial DNA and appears to act as a mitochondrial hormone regulating systemic metabolism. AMPK activation by MOTS-C overlaps with the same longevity pathways activated by caloric restriction and exercise — making this stack of significant interest to longevity researchers.
Protocol
Tirzepatide: 2.5–5 mg once weekly subcutaneous. MOTS-C: 5–10 mg once weekly subcutaneous. Duration: 12–24 weeks for full metabolic remodelling.
For laboratory use only. Not for human consumption.
Expected Timeline
Weeks 1–4
Metabolic Reset
Appetite normalisation begins within first week of Tirzepatide. MOTS-C begins improving cellular insulin sensitivity. Early weight and glucose improvements.
Weeks 5–12
Active Fat Loss
Sustained caloric deficit achieved through appetite regulation. Mitochondrial efficiency improving. Body composition measurably shifting.
Weeks 13–24
Metabolic Remodelling
Set point adaptation. Sustained improvements in fasting glucose, insulin sensitivity, and lipid profiles. Long-term metabolic health markers improving.
Who Is This Stack For?
Researchers studying metabolic syndrome, obesity pharmacology, type 2 diabetes mechanisms, mitochondrial biology, or GLP-1/GIP receptor pharmacology.
For Laboratory Use Only: All information is for educational purposes. Not medical advice. Not for human consumption. Consult a qualified physician before any use.
Source This Stack
Ready to Order the Metabolic Stack?
Tirzepatide + MOTS-C — all available directly from Pantheon Peptides.
Shop All Stack Peptides on Pantheon